Table S1. Phase separation and sensory results of preliminary trials.

Sample	t/day	Phase separation/%	Appearance	Body and texture	Aroma and flavour
Ctr 1	1	11.5±2.0	5.0±0.0	4.6±0.34	4.1±0.2
	7	25.0±3.5	4.9±0.3	4.2±0.3	4.0±0.3
	15	27.5±4.5	4.6±0.2	4.2±0.3	4.0±0.5
MG-0	1	10.0±2.5	4.5±0.3	4.5±0.3	4.4±0.4
	7	22.0±4.0	4.8±0.4	4.5±0.5	4.0±0.4
	15	23.0±2.0	4.5±0.3	4.0±0.3	2.7±0.2
MTG-0.5	1	2.50±0.5	5.0±0.0	4.7±0.3	4.6±0.5
	7	10.0±3.0	5.0±0.0	4.6±0.3	4.3±0.3
	15	18.5±3.5	4.7±0.2	4.8±0.4	4.3±0.2
MTG-1.0	1	2.8±1.3	5.0±0.0	4.6±0.3	4.5±0.3
	7	13.0±2.0	5.0±0.0	4.5±0.3	4.1±0.3
	15	20.0±2.5	4.8±0.7	4.7±0.3	4.0±0.2
MTG-1.5	1	6.5±1.5	4.4±0.2	4.0±0.5	4.4±0.2
	7	16.0±2.0	4.5±0.4	4.3±0.4	4.1±0.4
	15	21.5±3.5	4.6±0.2	4.1±0.4	3.4±0.2

Values are presented as mean±S.E. (N=2). Ctr 1=control sample without RWP or MTG; MTG-0, MTG-0.5 and MTG-1.0 and MTG-1.5=ayran sample with 0.0, 0.5, 1.0 and 1.5 U per g MTG; MTG=microbial transglutaminase